Crossmark

Cannabis for pediatric epilepsy: protocol for a living systematic review

Crossref DOI link: https://doi.org/10.1186/s13643-018-0761-2

Published Online: 2018-07-18

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elliott, Jesse https://orcid.org/0000-0002-2501-1641
DeJean, Deirdre

Clifford, Tammy

Coyle, Doug

Potter, Beth

Skidmore, Becky

Alexander, Christine

Repetski, Alexander E.

McCoy, Bláthnaid

Wells, George A.
License Information

Text and Data Mining valid from 2018-07-18
More Information

Article History

Received: 6 February 2018

Accepted: 24 June 2018

First Online: 18 July 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: Bláthnaid McCoy is the principal investigator in a study of cannabinoids for Dravet syndrome. Alexander Repetski is a director of communications at a licensed cannabis producer. The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.